📰 David Clair News
Page 2 - David Clair News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from David Clair. Real-time updates on events, politics, business and more.
April 10, 2024
/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday, May 1, 2024, at...
March 12, 2024
/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Will Geist, President, Protein Sciences Segment, will present at the KeyBanc Life...
February 1, 2024
MINNEAPOLIS, Feb. 1, 2024 /PRNewswire/ -- Bio-Techne Corporation today reported its financial results for the second quarter ended December 31, 2023. Second Quarter FY2024 Highlights Second quarter...
February 1, 2024
/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.08 per share for the quarter...
January 25, 2024
/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that its spatial biology brands, Lunaphore and Advanced Cell Diagnostics (ACD), will...
January 24, 2024
MINNEAPOLIS, Jan. 24, 2024 /PRNewswire/ -- Bio-Techne Corporation had the honor of welcoming presentations from leading scientists from two major biopharmaceutical companies, Pfizer and Sanofi, at...
January 5, 2024
MINNEAPOLIS, Jan. 5, 2024 /PRNewswire/ -- Bio-Techne Corporation today announced Matthew F. McManus has been appointed President, Diagnostics and Genomics Segment, effective January 8, 2024....
January 4, 2024
MINNEAPOLIS, Jan. 4, 2024 /PRNewswire/ -- Bio-Techne Corporation today announced it will present its portfolio of products and solutions to enable cell and gene therapy development and...
December 21, 2023
MINNEAPOLIS, Dec. 21, 2023 /PRNewswire/ -- Bio-Techne Corporation today announced that Kim Kelderman, current Chief Operating Officer, and Chief Executive Officer effective February 1, 2024, will...
December 20, 2023
/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it has filed a Drug Master File (DMF) with the U.S. Food and Drug Administration...